Required therapeutic dose of 131I for thyroid ablation after surgery for differentiated thyroid carcinoma

被引：0
|
作者：
Yaneva, M. [1 ]
Botushanova, A. [1 ]
机构：
[1] UMBAL St George Plovdiv, Plovdiv, Bulgaria
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2013年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S399 / S399
页数：1
相关论文
共 50 条
  • [21] Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma
    Gerali, S
    Koutsikos, J
    Tsiouris, S
    Mainta, E
    Lucchetti, S
    Papathanasiou, G
    Fotinaki, E
    Makripoulias, V
    Kotsias, D
    Palestidis, C
    Zerva, C
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S425 - S425
  • [22] Radiation dose rates of differentiated thyroid cancer patients after 131I therapy
    Pingyan Jin
    Huijuan Feng
    Wei Ouyang
    Juqing Wu
    Pan Chen
    Jing Wang
    Yungang Sun
    Jialang Xian
    Liuhua Huang
    Radiation and Environmental Biophysics, 2018, 57 : 169 - 177
  • [23] Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma
    Zerva, C.
    Koutsikos, J.
    Palestidis, C.
    Kounadi, E.
    Gerali, S.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 50 (04): : 348 - 354
  • [24] To Ablate or Not to Ablate: Issues and Evidence Involved in 131I Ablation of Residual Thyroid Tissue in Patients with Differentiated Thyroid Carcinoma
    Goldsmith, Stanley J.
    SEMINARS IN NUCLEAR MEDICINE, 2011, 41 (02) : 96 - 104
  • [25] Therapeutic administration of 131I for differentiated thyroid cancer:: Radiation dose to ovaries and outcome of pregnancies
    Garsi, Jerome-Philippe
    Schlumberger, Martin
    Rubino, Carole
    Ricard, Marcel
    Labbe, Martine
    Ceccarelli, Claudia
    Schvartz, Claire
    Henri-Amar, Michel
    Bardet, Stephane
    de Vathaire, Florent
    JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (05) : 845 - 852
  • [26] Bone Marrow Function After 131I Therapy in Patients With Differentiated Thyroid Carcinoma
    Prinsen, Hester T.
    Hesselink, Esther N. Klein
    Brouwers, Adrienne H.
    Plukker, John T. M.
    Sluiter, Wim J.
    van der Horst-Schrivers, Anouk N. A.
    van Imhoff, Gustaaf W.
    Links, Thera P.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (10): : 3911 - 3917
  • [27] Diagnostic 131I whole body scanning after thyroidectomy and ablation for differentiated thyroid cancer
    Taylor, H
    Hyer, S
    Vini, L
    Pratt, B
    Cook, G
    Harmer, C
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 150 (05) : 649 - 653
  • [28] Therapeutic safety evaluation of sodium glycididazole combined with 131I radiotherapy for differentiated thyroid carcinoma
    Sun Wenwei
    Gu Xinquan
    Gao Shi
    Bai Lin
    Cui Qu
    Ma Qingjie
    Wang Qing
    Zhao Guoqing
    NUCLEAR SCIENCE AND TECHNIQUES, 2011, 22 (04) : 212 - 216
  • [29] Therapeutic safety evaluation of sodium glycididazole combined with 131I radiotherapy for differentiated thyroid carcinoma
    SUN Wenwei GU Xinquan# GAO Shi BAI Lin CUI Qu MA Qingjie Wang Qing Zhao Guoqing China-Japan Union Hospital
    NuclearScienceandTechniques, 2011, 22 (04) : 212 - 216
  • [30] 131I treatment for brain metastases from differentiated thyroid carcinoma
    YU Yong-Li
    Nuclear Science and Techniques, 2004, (04) : 223 - 226
12345